High Body Mass Index Shortens Retention of Tumor Necrosis Factor-α Blocker Treatment in Rheumatoid Arthritis

被引：0
|
作者：
Elkayam, Ori [1 ]
Lidar, Merav [2 ]
Reitblat, Tatiana [3 ]
Zisman, Devy [4 ]
Balbir-Gurman, Alexandra [5 ]
Kakakian, Odelia [1 ]
Meshiach, Tanya [5 ]
Almog, Ronit [6 ]
Elalouf, Ofir [1 ]
机构：
[1] Tel Aviv Med Ctr & Sch Med, Tel Aviv, Israel
[2] Sheba Med Ctr, Rheumatol Unit, Ramat Gan, Israel
[3] Barzilai Govt Hosp, Ashqelon, Israel
[4] Carmel Hosp, Haifa, Israel
[5] Rambam Med Ctr, Haifa, Israel
[6] Rambam Hlth Care Campus, Epidemiol & Biostat Unit 7, Haifa, Israel
来源：
ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2359
引用
收藏
页数：2
相关论文
共 50 条
  • [1] High Body Mass Index is Associated with Shorter Retention of Tumor Necrosis Factor-Alpha Blocker Treatment in Rheumatoid Arthritis
    Elalouf, Ofir
    Lidar, Merav
    Reitblat, Tatiana
    Zisman, Devy
    Balbir-Gurman, Alexandra
    Hakakian, Odelia
    Mashiach, Tanya
    Almog, Ronit
    Elkayam, Ori
    [J]. BIOLOGICS-TARGETS & THERAPY, 2021, 15 : 279 - 287
  • [2] Tumor necrosis factor-α blockade in the treatment of rheumatoid arthritis
    Keystone, EC
    [J]. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2001, 27 (02) : 427 - 443
  • [3] Tumor necrosis factor-α production is associated with less body cell mass in women with rheumatoid arthritis
    Walsmith, J
    Abad, L
    Kehayias, J
    Roubenoff, R
    [J]. JOURNAL OF RHEUMATOLOGY, 2004, 31 (01) : 23 - 29
  • [4] Tumor necrosis factor-α (TNF) production is associated with lower body cell mass in rheumatoid arthritis [RA].
    Walsmith, J
    Snydman, L
    Roubenoff, R
    [J]. ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S80 - S80
  • [5] The Influence Of Body Mass Index On The Efficacy Of Tumor Necrosis Factor Blocking Therapy For Rheumatoid Arthritis.
    Visman, Ingrid M.
    van den Oever, Inge A. M.
    Krieckaert, Charlotte L. M.
    Wolbink, Gertjan
    Nurmohamed, Michael T.
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S602 - S602
  • [6] Predictors of Treatment Initiation with Tumor Necrosis Factor-α Inhibitors in Patients with Rheumatoid Arthritis
    Desai, Rishi J.
    Rao, Jaya K.
    Hansen, Richard A.
    Fang, Gang
    Maciejewski, Matthew L.
    Farley, Joel F.
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2014, 20 (11): : 1110 - 1120
  • [7] Secondary syphilis following tumor necrosis factor-α inhibitor treatment for rheumatoid arthritis
    Asahina, Akihiko
    Ishii, Norihisa
    Tohma, Shigeto
    [J]. JOURNAL OF DERMATOLOGY, 2012, 39 (02): : 199 - 201
  • [8] Development of Rheumatoid Nodules after Anti-Tumor Necrosis Factor-α Treatment with Adalimumab for Rheumatoid Arthritis
    Shin, Sungsik
    Chung, Kee Yang
    Kim, Dae Suk
    [J]. ANNALS OF DERMATOLOGY, 2016, 28 (03) : 402 - 403
  • [9] Tumor Necrosis Factor-α Blocker Induced Tuberculosis
    Kharbanda, Priyanka
    Dagaonkar, Rucha
    Balakrishnan, Canchi
    Udwadia, Zarir F.
    [J]. JOURNAL OF RHEUMATOLOGY, 2010, 37 (07) : 1542 - 1543
  • [10] Novel pathways that regulate tumor necrosis factor-α production in rheumatoid arthritis
    Gracie, JA
    Leung, BP
    McInnes, IB
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2002, 14 (03) : 270 - 275
12345